Literature DB >> 14985104

Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma.

Jhy-Shrian Huang1, Chuan-Chuan Chao, Teh-Li Su, Shiou-Hwei Yeh, Ding-Shinn Chen, Chiung-Tong Chen, Pei-Jer Chen, Yuh-Shan Jou.   

Abstract

For isolation of novel cellular transforming genes that potentially participated in hepatocarcinogenesis, we conducted anchorage-independent growth (AIG) assays on 10 human liver cancer cell lines and observed strong AIG capabilities in PLC5 and Huh7 but negligible in Tong cells. After cloning of genes by differential subtractive chain reactions (DSC) from strong AIG to AIG negative cells, we sequenced 2304 clones and identified 245 genes. After four stringent criteria for selection of transforming genes among DSC clones, our results of quantitative RT-PCR analysis indicated that six genes, DDX3, EIF3S2, CLIC1, HDGF, GPC3, and HSPCA were overexpressed in 64%, 62%, 60%, 58%, 49%, and 47%, respectively, of 45 hepatocellular carcinoma (HCC) tissues. The results of cellular transformation capability by AIG assays indicated that the transfectants of EIF3S2 showed the strongest (> 100-fold), DDX3 and CLIC1 were moderate, GPC3 and HSPCA were weak, and HDGF was none in forming colonies in soft agar. Together, our results suggested that Tong is a suitable human cell line for screening of overexpressed and/or cellular transforming genes. In addition, our results suggested that diverse functions of cellular transforming genes in various biological pathways could transform human Tong cells and potentially reveal new targets for drug development of HCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985104     DOI: 10.1016/j.bbrc.2004.01.151

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  71 in total

1.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

2.  Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Authors:  Paul C Schröder; Joaquín Fernández-Irigoyen; Emilie Bigaud; Antonio Serna; Rubén Renández-Alcoceba; Shelly C Lu; José M Mato; Jesús Prieto; Fernando J Corrales
Journal:  J Proteomics       Date:  2012-01-16       Impact factor: 4.044

3.  Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization.

Authors:  Shiow-Ching Shun; Yeur-Hur Lai; Ting-Ting Jing; Chii Jeng; Fa-Yau Lee; Li-Shia Hu; Sue-Yueh Cheng
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

4.  Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.

Authors:  Chi-Ming Chiu; Shiou-Hwei Yeh; Pei-Jer Chen; Ti-Jung Kuo; Ching-Ju Chang; Po-Jen Chen; Wan-Jen Yang; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

Review 5.  Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

Authors:  Megha Haridas Upadya; Jude Juventus Aweya; Yee-Joo Tan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 6.  Proteomic research progress in lymphatic metastases of cancers.

Authors:  Junwei Zong; Chunmei Guo; Shuqing Liu; Ming-Zhong Sun; Jianwu Tang
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

7.  Chloride intracellular channel 1 regulates colon cancer cell migration and invasion through ROS/ERK pathway.

Authors:  Pan Wang; Yun Zeng; Tao Liu; Chao Zhang; Pei-Wu Yu; Ying-Xue Hao; Hua-Xin Luo; Gang Liu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).

Authors:  Teruhisa Yamamoto; Hideji Nakamura; Weidong Liu; Ke Cao; Shohei Yoshikawa; Hirayuki Enomoto; Yoshinori Iwata; Noritoshi Koh; Masaki Saito; Hiroyasu Imanishi; Soji Shimomura; Hiroko Iijima; Toshikazu Hada; Shuhei Nishiguchi
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

9.  Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.

Authors:  Chaomin Sun; Cara T Pager; Guangxiang Luo; Peter Sarnow; Jamie H D Cate
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.

Authors:  Allan G N Angus; David Dalrymple; Steeve Boulant; David R McGivern; Reginald F Clayton; Martin J Scott; Richard Adair; Susan Graham; Ania M Owsianka; Paul Targett-Adams; Kui Li; Takaji Wakita; John McLauchlan; Stanley M Lemon; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-09-30       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.